AQR Capital Management - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,993,859
+307.8%
125,637
+384.9%
0.00%
+300.0%
Q2 2023$488,959
+413.9%
25,912
+4.6%
0.00%
Q1 2023$95,148
-26.7%
24,778
-5.3%
0.00%
Q4 2022$129,833
+3.9%
26,1760.0%0.00%
Q3 2022$125,000
-8.8%
26,176
-13.9%
0.00%
Q2 2022$137,000
-88.0%
30,392
-87.4%
0.00%
-100.0%
Q1 2022$1,144,000
-19.9%
240,321
+24.8%
0.00%
-33.3%
Q4 2021$1,429,000
+31.9%
192,558
+0.8%
0.00%
+50.0%
Q3 2021$1,083,000
-24.7%
190,937
-12.6%
0.00%0.0%
Q2 2021$1,439,000
+31.3%
218,353
+61.3%
0.00%0.0%
Q1 2021$1,096,000
+88.0%
135,348
+49.7%
0.00%
+100.0%
Q4 2020$583,000
-31.6%
90,416
-61.8%
0.00%0.0%
Q3 2020$852,000
-46.7%
236,529
-31.9%
0.00%
-66.7%
Q2 2020$1,598,000
+68.6%
347,314
+24.9%
0.00%
+50.0%
Q1 2020$948,000
-21.4%
278,128
+17.7%
0.00%
+100.0%
Q4 2019$1,206,000
+146.6%
236,248
+16.9%
0.00%0.0%
Q3 2019$489,000
+244.4%
202,084
+207.9%
0.00%
Q2 2019$142,000
-69.5%
65,623
-61.8%
0.00%
Q1 2019$465,000
+38.4%
171,644
+145.0%
0.00%
Q4 2018$336,000
-50.4%
70,061
-2.1%
0.00%
-100.0%
Q3 2018$678,000
-0.3%
71,552
+2.4%
0.00%0.0%
Q2 2018$680,000
-20.7%
69,851
-14.3%
0.00%0.0%
Q1 2018$858,000
-66.1%
81,541
-79.4%
0.00%
-66.7%
Q4 2017$2,532,000
+438.7%
394,957
+542.2%
0.00%
+200.0%
Q3 2017$470,000
-48.1%
61,502
-51.7%
0.00%0.0%
Q2 2017$905,000
+229.1%
127,274
-5.7%
0.00%
Q4 2016$275,000
-38.1%
134,939
-18.4%
0.00%
-100.0%
Q3 2016$444,000
+82.7%
165,433
+481.1%
0.00%
Q1 2016$243,000
-86.6%
28,467
-78.7%
0.00%
-100.0%
Q4 2015$1,810,000
+60.9%
133,395
+13.8%
0.00%
+50.0%
Q3 2015$1,125,000
+446.1%
117,183
+409.5%
0.00%
Q1 2015$206,000
+47.1%
23,0000.0%0.00%
Q4 2014$140,000
-42.9%
23,000
-0.5%
0.00%
-100.0%
Q3 2014$245,000
-10.6%
23,1270.0%0.00%0.0%
Q2 2014$274,000
-20.6%
23,1270.0%0.00%0.0%
Q1 2014$345,000
+1.8%
23,1270.0%0.00%0.0%
Q4 2013$339,000
-14.0%
23,1270.0%0.00%0.0%
Q3 2013$394,000
+2.6%
23,1270.0%0.00%0.0%
Q2 2013$384,000
-25.4%
23,127
-42.8%
0.00%
-50.0%
Q4 2012$515,00040,4270.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders